"Aggressive breast cancer" trang 1 - tải miễn phí từ tailieunhanh
Outcome disparities in African American women with triple negative breast cancer: A comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer

Outcome disparities in African American women with triple negative breast cancer: A comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer
8    78    1
The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)

The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
8    85    1
Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: Impact of non-cytotoxic doses of 2-DG on diminishing invasiveness

Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: Impact of non-cytotoxic doses of 2-DG on diminishing invasiveness
13    39    1
An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer

An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer
12    1    1
Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo

Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo
14    45    0
Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells

Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
9    30    1
Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448

Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
18    47    1
Prognostic value of ERBB4 expression in patients with triple negative breast cancer

Prognostic value of ERBB4 expression in patients with triple negative breast cancer
12    51    1
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer

Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer
10    41    1
MicroRNA profile in very young women with breast cancer

MicroRNA profile in very young women with breast cancer
14    50    1
Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients

Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients
11    80    1
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma

A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma
12    56    1
Association between NDRG1 protein expression and aggressive features of breast cancer: A systematic review and meta-analysis

Association between NDRG1 protein expression and aggressive features of breast cancer: A systematic review and meta-analysis
11    8    1
Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation

Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation
20    50    1
Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration

Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration
15    36    1
Confocal laser endomicroscopy in breast surgery: A pilot study

Confocal laser endomicroscopy in breast surgery: A pilot study
7    37    1
Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers

Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers
8    53    1
High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability

High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability
11    51    1